Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus

Cancer Journal from Scientific American

Volumn 3, Issue 3, 1997, Pages 144-152

  Forastiere, Arlene A ^a,b   Heitmiller, Richard F ^a   Lee, Ding Jen ^a   Zahurak, Marianna ^a   Abrams, Ross ^a   Kleinberg, Lawrence ^a   Watkins, Stanley ^a   Yeo, Charles J ^a   Lillemoe, Keith D ^a   Sitzmann, James V ^a   Sharfman, William ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

chemotherapy; cisplatin; combined modality therapy; Esophageal cancer; radiation

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; NEUROTOXICITY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SEPSIS; SQUAMOUS CELL CARCINOMA; STOMATITIS; WEIGHT REDUCTION;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; SURVIVAL ANALYSIS; THROMBOCYTOPENIA;

EID: 0030922971     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Flood WA, Forastiere AA. Esophageal cancer. Curr Opin Oncol 1995;7:381-386.
2. Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol 1994;21:403-410.
3. Orringer MB. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg 1984;200:282-287.
4. Muller JM, Erassmi H, Stelzner M et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1996;77:845-857.
5. Roth JA, Putnam JB, Jr. Surgery for cancer of the esophagus. Semin Oncol 1994;21:453-461.
6. Ellis HF, Jr. Treatment of carcinoma of the esophagus or cardia. Mayo Clin Proc 1989;64:945-955.
7. Heitmiller RF, Forastiere AA. Management of specific malignancies: esophagus. In: Abeloff MD, Armitage JO, Lichter AS et al, eds. Clinical Oncology. New York: Churchill Livingstone, 1995.
8. Ilson DA, Kelsen DP. Combined modality therapy in the treatment of esophageal cancer. Semin Oncol 1994;21:493-507.
9. Forastiere AA, Gennis M, Orringer M et al. Cisplatin, vinblastine, and mitoguiazone chemotherapy for epidermoid and adenocarcinoma of the esophagus. J Clin Oncol 1987;5:1143-1149.
10. Forastiere, AA, Orringer MB, Perez-Tamayo C et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 1993;6:1118-1123.
11. Urba S, Orringer M, Turrisi A et al. A randomized trial comparing transhiatal esophagectomy to preoperative chemoradiation followed by esophagectomy in locoregional esophageal carcinoma. Proceedings of ASCO 1995;14:119.
12. Herskovic A, Martz K, Al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-1598.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistics Association 1958; 53:457-481.
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy 1996;50: 163-170.
15. Cox DR. Regression models and life table (with discussion). Journal of the Royal Statistical Society B 1972;34:187-220.
16. Cox DR: The Analysis of Binary Data. London: Methuen, 1970.
17. Forastiere AA, Orringer MB, Perez-Tamayo C et al. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol 1990;8:119-127.
18. Putnam JB, Jr., Suell DA, Natarajan G et al. A comparison of three techniques of esophagectomy for carcinoma of the esophagus from one institution with a residency training program. Ann Thorac Surg 1994;57:319-325.
19. Ajani JA, Ryan B, Rich TA et al. Prolonged chemotherapy for localized squamous carcinoma of the oesophagus. Eur J Cancer 1992;28A:880-884.
20. Sakai K, Inakoshi H, Sueyama H et al. Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1995;31:921-927.
21. Rich TA, Ajani JA. High dose external beam radiation therapy with or without concomitant chemotherapy for esophageal cancer. Ann Oncol 1994;5[suppl 3]:9-15.
22. Lokich JJ, Ahlgren JD, Gullo JJ et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program study. J Clin Oncol 1989;7:425-432.
23. O'Connell MJ, Martenson JA, Wieand HS et al. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil and radiation therapy after curative surgery. N Engl J Med 1994;331:502-507.
24. Rich T, Skibber J, Ajani J et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025-1029.
25. Rich TA. Chemoradiation or accelerated fractionation: basic considerations. Journal of Infusion Chemotherapy 1992;1:2-8.
26. Fisher B, Saffer EA, Deutsch M. Influence of irradiation of a primary tumor on the labeling index and estrogen receptor index in a distant tumor focus. Int J Radiat Oncol Biol Phys 1986;12: 879-885.
27. Kallman RF. The importance of schedule and drug dose intensity in combinations of modalities. Int J Radiat Oncol Biol Phys 1994; 28:761-771.
28. Schwachofer JHM, Crooijmans RPMA, Hoogenhout J et al. Effectiveness of inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. Int J Radiat Oncol Biol Phys 1991;20:1235-1241.
29. Forastiere AA, Beliveau JF, Goren MP et al. Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum (II) in head and neck cancer patients. Cancer Res 1988;48:3869-3874.
30. Heitmiller RF, Sharma RR. Comparison of prevalence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma. J Thorac Cardiovasc Surg 1996;112:130-136.
31. Lightdale CJ. Endoscopic ultrasound for the staging of esophageal and gastric cancer. Principles & Practice of Oncology Updates 1995;9:1-13.
32. Le Prise E, Etienne PL, Meunier B et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73:1779-1784.
33. Walsh TN, Noonan N, Hollywood D et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467.
34. Bosset JF, Gignoux M, Triboulet JP et al. Randomized phase III clinical trial comparing surgery alone versus pre-operative combined radiochemotherapy in stage I-II epidermoid cancer of the thoracic esophagus: preliminary analysis. Proceedings of ASCO 1994;13:197.
35. Bates BA, Detterbeck FC, Bernard SA et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996;14:156-163.
36. Bessell JR, Devitt PG, Gill PG et al. Prolonged survival follows resection of oesophageal SCC downstaged by prior chemoradiotherapy. Aust N Z J Surg 1996;66:214-217.
37. Burmeister BH, Denham JW, O'Brien M et al. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multi-center study. Int J Radiat Oncol Biol Phys 1995;32:997-1006.
38. Adelstein DJ, Rice TW, Becker M et al. Concurrent chemotherapy (CCT), accelerated fractionation radiation (AFR) and surgery for esophageal cancer. Proceedings of ASCO 1996;15:203.